-
). This consortium pulls together expertise from all over the University, including in diagnostics, data science, drug and vaccine design, preclinical testing and clinical testing and brings it to bear on tuberculosis
-
-resistant TB (OxCoD4TB). This consortium pulls together expertise from all over the University, including in diagnostics, data science, drug and vaccine design, preclinical testing and clinical testing and
-
of toxicity assay and translational criteria in drug development. Basic knowledge of one or more aspects of molecular design in therapeutic radiopharmaceuticals and molecular imaging probes. Knowledge in
-
in global health, and health and social care. Further information about the Faculty of Life Sciences and Medicine may be found at https://www.kcl.ac.uk/lsm/index.aspx Within FoLSM, the School
-
relevant for drug discovery analysis pipelines, trial design and operational efficiency. Led by Professor Chris Holmes, and with scientific oversight from Oxford Principal Investigators and GSK scientists